PIEKOS BRIAN (Chief Financial Officer) sold 11.4% of their position (1.77K shares) of KALVISTA PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $27.5K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/24/2026ACC: 0001815308-26-000002
Officer· Chief Financial Officer
Since Feb 2026
-1.77K
Net shares
Net seller
$27.5K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
5K acquired · 6.77K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+5K
Price / share
—
Trade value
—
% of position
47.5%
2/21/2026
10.53K→15.53K
Common Stock
Direct
Shares
−1.77K
Price / share
$15.57
Trade value
$27.51K
% of position
11.4%
2/23/2026
15.53K→13.76K
Total
Net shares
+3.23K
Net value
-$27.51K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/21/2026 | M · Option Exercise | +5K | — | — | 47.5% | 10.53K | 15.53K |
| Common Stock Direct | 2/23/2026 | S · Sale | −1.77K | $15.57 | $27.51K | 11.4% | 15.53K | 13.76K |
| Total | +3.23K | -$27.51K | ||||||
Derivative Transactions1
Restricted Stock Unit
Direct
Converts to
Common Stock
5K shares
Shares
−5K
Strike price
Held after
60K
Exercisable
—
2/21/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Unit Direct | Common Stock5K shares | 2/21/2026 | M · Option Exercise | −5K | — | 60K |